scispace - formally typeset
O

Omri Gottesman

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  75
Citations -  17706

Omri Gottesman is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Genome-wide association study & Population. The author has an hindex of 39, co-authored 72 publications receiving 15163 citations. Previous affiliations of Omri Gottesman include Regeneron & University of Split.

Papers
More filters

Genetic studies of body mass index yield new insights for obesity biology

Adam E. Locke, +481 more
TL;DR: This paper conducted a genome-wide association study and meta-analysis of body mass index (BMI), a measure commonly used to define obesity and assess adiposity, in up to 339,224 individuals.
Journal ArticleDOI

Defining the role of common variation in the genomic and biological architecture of adult human height

Andrew R. Wood, +444 more
- 01 Nov 2014 - 
TL;DR: This article identified 697 variants at genome-wide significance that together explained one-fifth of the heritability for adult height, and all common variants together captured 60% of heritability.
Journal ArticleDOI

A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease

Majid Nikpay, +167 more
- 07 Sep 2015 - 
TL;DR: This article conducted a meta-analysis of coronary artery disease (CAD) cases and controls, interrogating 6.7 million common (minor allele frequency (MAF) > 0.05) and 2.7 millions low-frequency (0.005 < MAF < 0.5) variants.
Journal ArticleDOI

Loss-of-function mutations in APOC3, triglycerides, and coronary disease

Jacy R Crosby, +96 more
TL;DR: Rare mutations that disrupt AP OC3 function were associated with lower levels of plasma triglycerides and APOC3, and carriers of these mutations were found to have a reduced risk of coronary heart disease.
Journal ArticleDOI

The genetic architecture of type 2 diabetes

Christian Fuchsberger, +349 more
- 11 Jul 2016 - 
TL;DR: In this paper, the authors performed whole-genome sequencing in 2,657 European individuals with and without diabetes, and exome sequencing for 12,940 individuals from five ancestry groups.